The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Open accessAbstract
Sulfur (SVI) based moieties, especially, the sulfonyl or sulfonamide based analogues have showed a variety of pharmacological properties, and its derivatives propose a high degree of structural diversity that has established useful for the finding of new therapeutic agents. The developments of new less toxic, low cost and highly active sulfonamides containing analogues are hot research topics in medicinal chemistry. Currently, more than 150 FDA approved Sulfur (SVI)-based drugs are available in the market, and they are widely used to treat various types of diseases with therapeutic power. This comprehensive review highlights the recent developments of sulfonyl or sulfonamides based compounds in huge range of therapeutic applications such as antimicrobial, anti-inflammatory, antiviral, anticonvulsant, antitubercular, antidiabetic, antileishmanial, carbonic anhydrase, antimalarial, anticancer and other medicinal agents. We believe that, this review article is useful to inspire new ideas for structural design and developments of less toxic and powerful Sulfur (SVI) based drugs against the numerous death-causing diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 1×
“Cannabinoid receptors 1 and 2 (CB1 and CB2, respectively) were considered to be the members of the G protein-coupled receptor (GPCR) superfamily in the early of 1990's [209,210].”
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Microvascular and Macrovascular Complications of Diabetes
Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.2.77 · Cited by 1,954
The Carbon Dioxide Hydration Activity of Carbonic Anhydrase
Khalifah, R. G. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62326-9 · Cited by 1,913
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
Drug development for neglected diseases: a deficient market and a public-health policy failure
Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09096-7 · Cited by 893
Treatment of Alzheimer's disease; current status and new perspectives
scarpini, E., Schelterns, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 721
Prostaglandin Endoperoxide H Synthases-1 and -2
Smith, W. L., & Dewitt, D. L. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60430-7 · Cited by 711
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
RUSSELL, S. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.147 · Cited by 650
Carbonic anhydrase inhibitors and their therapeutic potential
Supuran, C. T., & Scozzafava, A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.575 · Cited by 549
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Type 2 Diabetes in the Young: The Evolving Epidemic
Alberti, G., Zimmet, P., Shaw, J., Bloomgarden, Z., Kaufman, F., Silink, M., & for the Consensus Workshop Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1798 · Cited by 493
Targeting Antibiotic Resistance
Chellat, M. F., Raguž, L., & Riedl, R. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201506818 · Cited by 487
Dai, H.-X., Stepan, A. F., Plummer, M. S., Zhang, Y.-H., & Yu, J.-Q. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201708f · Cited by 480
Wang, X.-L., Wan, K., & Zhou, C.-H. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.07.031 · Cited by 376
Eron, J., Yeni, P., Gathe, J., Estrada, V., DeJesus, E., Staszewski, S., Lackey, P., Katlama, C., Young, B., Yau, L., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69155-1 · Cited by 344
Combination therapy for visceral leishmaniasis
van Griensven, J., Balasegaram, M., Meheus, F., Alvar, J., Lynen, L., & Boelaert, M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70011-6 · Cited by 336
Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
Bloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.998 · Cited by 325
Batsch, N., & Mittelman, M. S. (2012) · Cited by 325
Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes
Hilvo, M., Baranauskiene, L., Salzano, A. M., Scaloni, A., Matulis, D., Innocenti, A., Scozzafava, A., Monti, S. M., Di Fiore, A., De Simone, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800938200 · Cited by 307
Quinoline: A promising antitubercular target
Keri, R. S., & Patil, S. A. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.007 · Cited by 301
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Scozzafava, A., Supuran, C. T., & Carta, F. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.790957 · Cited by 273
Ryckmans, T., Edwards, M. P., Horne, V. A., Correia, A. M., Owen, D. R., Thompson, L. R., Tran, I., Tutt, M. F., & Young, T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.062 · Cited by 270
CPD — Education and self-assessment The epidemiology of epilepsy: the size of the problem
Bell, G. S., & Sander, J. W. (2001) · Seizure · doi:10.1053/seiz.2001.0584 · Cited by 214
Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
Marnett, L. J., & Kalgutkar, A. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01385-1 · Cited by 205
YEUNG, S., PONGTAVORNPINYO, W., HASTINGS, I. M., MILLS, A. J., & WHITE, N. J. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.179 · Cited by 197
Esnouf, R. M., Ren, J., Hopkins, A. L., Ross, C. K., Jones, E. Y., Stammers, D. K., & Stuart, D. I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3984 · Cited by 195
The Global Fight Against HIV/AIDS, Tuberculosis, and Malaria
Vitoria, M., Granich, R., Gilks, C. F., Gunneberg, C., Hosseini, M., Were, W., Raviglione, M., & De Cock, K. M. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp5xhdb1pnaeyt · Cited by 187
HIV drug resistance: problems and perspectives
Pennings, P. S. (2013) · Infectious Disease Reports · doi:10.4081/idr.2013.s1.e5 · Cited by 178
Luo, Z., Sheng, J., Sun, Y., Lu, C., Yan, J., Liu, A., Luo, H.-B., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401047q · Cited by 177
Scott, J. D., Li, S. W., Brunskill, A. P. J., Chen, X., Cox, K., Cumming, J. N., Forman, M., Gilbert, E. J., Hodgson, R. A., Hyde, L. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00307 · Cited by 174
Keche, A. P., Hatnapure, G. D., Tale, R. H., Rodge, A. H., Birajdar, S. S., & Kamble, V. M. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.092 · Cited by 170
Hassan, G. S., Abou‐Seri, S. M., Kamel, G. M., & Ali, M. M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.033 · Cited by 169
Messerli, F. H., Makani, H., Benjo, A., Romero, J., Alviar, C., & Bangalore, S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.053 · Cited by 169
Serotonin 5-HT6Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease
Benhamú, B., Martín-Fontecha, M., Vázquez-Villa, H., Pardo, L., & López-Rodríguez, M. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5003952 · Cited by 158
Bano, S., Javed, K., Ahmad, S., Rathish, I. G., Singh, S., & Alam, M. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.08.015 · Cited by 156
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs
Salerno, S., Settimo, F. D., Taliani, S., Simorini, F., Motta, C. L., Fornaciari, G., & Marini, A. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793361252 · Cited by 152
Novel sulphonamide derivatives for the treatment of cancer
Owa, T., & Nagasu, T. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.11.1725 · Cited by 149
Nasr, T., Bondock, S., & Eid, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.052 · Cited by 136
Shen, C., Wang, Y., Kovalevsky, A. Y., Harrison, R. W., & Weber, I. T. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07771.x · Cited by 135
Zhang, X., Rakesh, K. P., Bukhari, S. N. A., Moku, B., Manukumar, H. M. G., & Qin, H. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.06.009 · Cited by 132
Self-citationCarta, F., Maresca, A., Covarrubias, A. S., Mowbray, S. L., Jones, T. A., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.009 · Cited by 122
Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides
Moreno‐Díaz, H., Villalobos‐Molina, R., Ortíz‐Andrade, R., Dı́az-Coutiño, D., Medina‐Franco, J. L., Webster, S. P., Binnie, M., Estrada-Soto, S. E., Ibarra-Barajas, M., León‐Rivera, I., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.086 · Cited by 114
Lal, J., Gupta, S. K., Thavaselvam, D., & Agarwal, D. D. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.012 · Cited by 112
Targeting cannabinoid agonists for inflammatory and neuropathic pain
Cheng, Y., & Hitchcock, S. A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.951 · Cited by 111
Pinard, M. A., Boone, C. D., Magalis, B. R., Supuran, C. T., & McKENNA, R. V. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.033 · Cited by 110
Bashir, R., Ovais, S., Yaseen, S., Hamid, H., Alam, M. S., Samim, M., Singh, S., & Javed, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.061 · Cited by 108
Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies
Pingaew, R., Prachayasittikul, V., Worachartcheewan, A., Nantasenamat, C., Prachayasittikul, S., Ruchirawat, S., & Prachayasittikul, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.09.001 · Cited by 107
Garaj, V., Puccetti, L., Fasolis, G., Winum, J., Montero, J., Scozzafava, A., Vullo, D., Innocenti, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.087 · Cited by 107
Synthesis and SAR of sulfonyl- and phosphoryl amidine compounds as anti-resorptive agents
Lee, M. Y., Kim, M. H., Kim, J.-H., Kim, S. H., Kim, B., Jeong, I. H., Chang, S., Kim, S. H., & Chang, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.104 · Cited by 103
Novel approaches to epilepsy treatment
Sørensen, A. T., & Kokaia, M. (2012) · Epilepsia · doi:10.1111/epi.12000 · Cited by 103
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report
Morens, D. M., & Fauci, A. S. (2012) · mBio · doi:10.1128/mbio.00494-12 · Cited by 97
Sulfonamides as multifunctional agents for Alzheimer’s disease
Bag, S., Tulsan, R., Sood, A., Cho, H., Redjeb, H., Zhou, W., LeVine, H., Török, B., & Török, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.006 · Cited by 96
Al-Riyami, L., Pineda, M. A., Rzepecka, J., Huggan, J. K., Khalaf, A. I., Suckling, C. J., Scott, F. J., Rodgers, D. T., Harnett, M. M., & Harnett, W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401251p · Cited by 94
Ward, A., & Brogden, R. N. (1988) · Drugs · doi:10.2165/00003495-198836060-00004 · Cited by 92
Więckowska, A., Kołaczkowski, M., Bucki, A., Godyń, J., Marcinkowska, M., Więckowski, K., Zaręba, P., Siwek, A., Kazek, G., Głuch-Lutwin, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.016 · Cited by 91
Inhibition of HIV-1 Replication by Isoxazolidine and Isoxazole Sulfonamides
Loh, B., Vozzolo, L., Mok, B., Lee, C.-C., Fitzmaurice, R. J., Caddick, S., & Fassati, A. (2010) · Chemical Biology and Drug Design · doi:10.1111/j.1747-0285.2010.00956.x · Cited by 88
Zhou, D., Xie, D., He, F., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.04.042 · Cited by 86
1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors
Klopfenstein, S. R., Evdokimov, A. G., Colson, A., Fairweather, N. T., Neuman, J. J., Maier, M. B., Gray, J. L., Gerwe, G. S., Stake, G. E., Howard, B. W., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.051 · Cited by 84
Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors
Moretto, A. F., Kirincich, S. J., Xu, W.-B., Smith, M. J., Wan, Z., Wilson, D. P., Follows, B., Binnun, E., Joseph‐McCarthy, D., Foreman, K. W., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.005 · Cited by 83
Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors
Pingaew, R., Prachayasittikul, V., Mandi, P., Nantasenamat, C., Prachayasittikul, S., Ruchirawat, S., & Prachayasittikul, V. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.036 · Cited by 83
Humphries, P. S., Bersot, R., Kincaid, J., Mabery, E. M., McCluskie, K., Park, T., Renner, T., Riegler, E., Steinfeld, T., Turtle, E. D., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.102 · Cited by 83
Riaz, S., Khan, I. U., Bajda, M., Ashraf, M., Qurat‐ul‐Ain, Shaukat, A., Rehman, T. U., Mutahir, S., Hussain, S., Mustafa, G., et al. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.09.008 · Cited by 77
Synthesis and antifungal properties of sulfanilamide derivatives of chitosan
Zhong, Z., Chen, R., Xing, R., Chen, X., Liu, S., Guo, Z., Ji, X., Wang, L., & Li, P. (2007) · Carbohydrate Research · doi:10.1016/j.carres.2007.07.015 · Cited by 74
Mutahir, S., Jończyk, J., Bajda, M., Khan, I. U., Khan, M. A., Ullah, N., Ashraf, M., Qurat‐ul‐Ain, Riaz, S., Hussain, S., et al. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.11.002 · Cited by 73
Tan, L. P., Wu, H., Yang, P., Kalesh, K., Zhang, X., Hu, M., Srinivasan, R., & Yao, S. Q. (2009) · Organic Letters · doi:10.1021/ol9023419 · Cited by 72
An Overview of SR121463, a Selective Non‐Peptide Vasopressin V2Receptor Antagonist
Gal, C. S. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00065.x · Cited by 72
Chandna, N., Kumar, S., Kaushik, P., Kaushik, D., Roy, S. K., Gupta, G. K., Jachak, S. M., Kapoor, J. K., & Sharma, P. K. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.029 · Cited by 70
Taha, M., Irshad, M., Imran, S., Chigurupati, S., Selvaraj, M., Rahim, F., Ismail, N. H., Nawaz, F., & Khan, K. M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.028 · Cited by 70
Košak, U., Knez, D., Coquelle, N., Brus, B., Pišlar, A. H., Nachon, F., Brazzolotto, X., Kos, J., Colletier, J., & Gobec, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.032 · Cited by 67
Sulphonamides: Deserving class as MMP inhibitors?
Jain, P., Saravanan, C., & Singh, S. K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.016 · Cited by 66
Wang, Z., Qin, Y.-J., Wang, P., Yang, Y.-A., Wen, Q., Zhang, X., Qiu, H., Duan, Y., Wang, Y., Sang, Y.-L., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.035 · Cited by 65
Role of Sulfonamide Group in Matrix Metalloproteinase Inhibitors
Cheng, X., Wang, Q., Fang, H., et al. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783497300 · Cited by 65
Naim, M. J., Alam, O., Alam, M. J., Hassan, M. Q., Siddiqui, N., Naidu, V. G. M., & Alam, I. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.11.010 · Cited by 64
Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides
Alaoui, S. M., Dufies, M., Driowya, M., Demange, L., Bougrin, K., Robert, G., Auberger, P., Pagès, G., & Benhida, R. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.018 · Cited by 61
Mechanism of action of novel anti-inflammatory drugs diflumidone and R-805
Vigdahl, R. L., & Tukey, R. H. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90182-4 · Cited by 60
Kirane, A., Toombs, J. E., Ostapoff, K. T., Carbon, J. G., Zaknoen, S. L., Braunfeld, J. B., Schwarz, R. E., Burrows, F. J., & Brekken, R. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0453 · Cited by 59
Gao, H.-D., Liu, P., Yang, Y., & Gao, F. (2016) · RSC Advances · doi:10.1039/c6ra15948f · Cited by 59
Kim, J., Ryu, H. W., Shim, J. H., Park, K. H., & Withers, S. G. (2009) · ChemBioChem · doi:10.1002/cbic.200900108 · Cited by 58
Inhibitory Evaluation of Sulfonamide Chalcones on β-Secretase and Acylcholinesterase
Kang, J. S., Cho, J. R., Long, M. J. C., Ryu, H., Kim, J., Kim, H. J., Yuk, H. J., Kim, D. J., & Park, K. H. (2012) · Molecules · doi:10.3390/molecules18010140 · Cited by 58
Akurathi, V., Dubois, L. J., Celen, S., Lieuwes, N. G., Chitneni, S. K., Cleynhens, B. J., Innocenti, A., Supuran, C. T., Verbruggen, A., Lambin, P., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.027 · Cited by 57
Romero, G., Sánchez, E., Pujol, M., Pérez, P., Codony, X., Holenz, J., Buschmann, H., & Pauwels, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706827 · Cited by 57
Quintana, C., Silva, G., Klahn, A. H., Artigas, V., Fuentealba, M., Biot, C., Halloum, I., Kremer, L., Novoa, N., & Arancibia, R. (2017) · Polyhedron · doi:10.1016/j.poly.2017.06.015 · Cited by 57
Andrighetti, C. R., de Oliveira, K. N., Gaspar-Silva, D., Pacheco, L. K., Joussef, A. C., Steindel, M., Simões, C. M. O., de Souza, A. M. T., Magalhães, U. O., Afonso, I. F., et al. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.016 · Cited by 56
El‐Din, M. M. M., Senbel, A. M., Bistawros, A., El‐Mallah, A., El‐Din, N. A. N., Bekhit, A. A., & Razik, H. A. A. E. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00648.x · Cited by 55
Ali, A., Reddy, G. S., Nalam, M. N. L., Anjum, S. G., Cao, H., Schiffer, C. A., & Rana, T. M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1008743 · Cited by 55
Gorantla, V., Gundla, R., Jadav, S. S., Anugu, S. R., Chimakurthy, J., Nidasanametla, S. K. R., & Korupolu, R. (2017) · New Journal of Chemistry · doi:10.1039/c7nj03332j · Cited by 55
Navarrete‐Vázquez, G., Paoli, P., León‐Rivera, I., Villalobos‐Molina, R., Medina‐Franco, J. L., Ortíz‐Andrade, R., Estrada-Soto, S. E., Camici, G., Díaz-Coutiño, D., Gallardo‐Ortíz, I. A., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.03.042 · Cited by 53
Hrast, M., Turk, S., Sosič, I., Knez, D., Randall, C. P., Barreteau, H., Contreras‐Martel, C., Dessen, A., O’Neill, A. J., Mengin‐Lecreulx, D., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.05.013 · Cited by 52
Dofetilide, a New Class III Antiarrhythmic Agent
Lenz, T. L., & Hilleman, D. E. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.9.776.35208 · Cited by 51
Julémont, F., de Leval, X., Michaux, C., Renard, J.-F., Winum, J., Montero, J., Damas, J., Dogné, J., & Pirotte, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049480l · Cited by 50
Zhang, N., Zhang, X., Zhu, J., Turpoff, A., Chen, G., Morrill, C., Huang, S., Lennox, W., Kakarla, R., Liu, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401621g · Cited by 50
Devender, N., Gunjan, S., Tripathi, R., & Tripathi, R. P. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.010 · Cited by 50
Perspective on race and ethnicity in Alzheimer's disease research
Weiner, M. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.016 · Cited by 48
Benzouracil–coumarin–arene conjugates as inhibiting agents for chikungunya virus
Hwu, J. R., Kapoor, M., Tsay, S., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.013 · Cited by 46
Plant Derived Antivirals: A Potential Source of Drug Development
Ganju, S. S. L. (2013) · Journal of Virology & Antiviral Research · doi:10.4172/2324-8955.1000109 · Cited by 45
Huang, H., Lü, W., Li, X., Cong, X., Ma, H., Liu, X., Zhang, Y., Che, P., Ma, R., Li, H., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.011 · Cited by 45
Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide
Hamaguchi, T., Hirose, T., Asakawa, H., Itoh, Y., Kamado, K., Tokunaga, K., Tomita, K., Masuda, H., Watanabe, N., & Namba, M. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.12.012 · Cited by 44
Mohammed, K. O., & Nissan, Y. M. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12336 · Cited by 42
Muthas, D., Nöteberg, D., Sabnis, Y. A., Hamelink, E., Vrang, L., Samuelsson, B., Karlén, A., & Hallberg, A. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.048 · Cited by 40
da Silva, L. E., Joussef, A. C., Pacheco, L. K., Gaspar-Silva, D., Steindel, M., & Rebelo, R. A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.09.007 · Cited by 40
Elgaher, W. A. M., Sharma, K. K., Haupenthal, J., Saladini, F., Pires, M., Réal, É., Mély, Y., & Hartmann, R. W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00730 · Cited by 39
Thakur, A., Manohar, S., Gerena, C. E. V., Zayas, B., Kumar, V., Malhotra, S. V., & Rawat, D. S. (2014) · MedChemComm · doi:10.1039/c3md00399j · Cited by 38
Chang, C., Wu, C.-H., Song, J., Chou, M., Wong, Y., Lin, Y., Yeh, T., Sadani, A. A., Ou, M., Chen, K.-H., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401158e · Cited by 37
Naidu, K. M., Suresh, A., Jayanty, S., Sriram, D., Yogeeswari, P., Raghavaiah, P., & Sekhar, K. V. G. C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.043 · Cited by 37
New Pyrazolobenzothiazine Derivatives as Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors
Manfroni, G., Manvar, D., Barreca, M. L., Kaushik‐Basu, N., Leyssen, P., Paeshuyse, J., Cannalire, R., Iraci, N., Basu, A., Chudaev, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401688h · Cited by 37
Caridha, D. P., Kathcart, A. K., Jirage, D., & Waters, N. C. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.039 · Cited by 36
Ulus, R., Kurt, B. Z., Gazioğlu, I., & Kaya, M. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.01.005 · Cited by 36
Frkic, R. L., He, Y., Rodriguez, B. B., Chang, M. R., Kuruvilla, D. S., Ciesla, A., Abell, A. D., Kamenecka, T. M., Griffin, P. R., & Bruning, J. B. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01727 · Cited by 36
Wang, W., Ao, L., Rayburn, E. R., Xu, H., Zhang, X., Zhang, X., Nag, S. A., Wu, X., Wang, M., Wang, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044883 · Cited by 32
Oliveira, M. D., Cenzi, G., Nunes, R. R., Andrighetti, C. R., Valadão, D. D. S., Reis, C. D., Simões, C. M. O., Nunes, R. D. C., Júnior, M., Taranto, A. G., et al. (2013) · Molecules · doi:10.3390/molecules181215276 · Cited by 32
Türkmen, H., Zengin, G., & Buyukkircali, B. (2011) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2011.02.004 · Cited by 31
5-Sulfonyl-benzimidazoles as selective CB2 agonists-Part 2
Gijsen, H. J. M., Cleyn, M. A. J. D., Surkyn, M., Lommen, G. R. E. V., Verbist, B. M. P., Nijsen, M., Meert, T. F., Wauwe, J. V., & Aerssens, J. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.091 · Cited by 31
Abdellatif, K. R. A., & Fadaly, W. A. A. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.04.002 · Cited by 31
Optimisation of a novel series of selective CNS penetrant CB2 agonists
Watson, C. A., Owen, D. R., Harding, D., Kon‐i, K., Lewis, M. L., Mason, H. J., Matsumizu, M., MUKAIYAMA, T., Rodriguez‐Lens, M., Shima, A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.063 · Cited by 27
D’Amico, D. C., Aya, T., Human, J. B., Fotsch, C. H., Chen, J. J., Biswas, K., Riahi, B., Norman, M. H., Willoughby, C. A., Hungate, R. W., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061224g · Cited by 26
Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators
Greig, I. R., Baillie, G. L., Abdelrahman, M., Trembleau, L., & Ross, R. A. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.018 · Cited by 26
Soeberdt, M., Molenveld, P., Storcken, R. P. M., Mazery, R. D., Sterk, G. J., Autar, R. S., Bolster, M. G., Wagner, C., Aerts, S. N. H., van Holst, F. R., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01868 · Cited by 25
Rehman, T. U., Khan, I. U., Ashraf, M., Tarazi, H., Riaz, S., & Yar, M. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201600304 · Cited by 23
Du, Y., Zhang, Y. H., Ling, H., Li, Q., & Shen, J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.064 · Cited by 23
Bajare, S., Anthony, J., Nair, A. S., Marita, R., Damre, A. A., Patel, D. J., B‐Rao, C., Sivaramakrishnan, H., & Deka, N. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.027 · Cited by 18
Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors
Wang, Q., Cheng, N., Zheng, X.-W., Peng, S., & Zou, X.-Q. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.066 · Cited by 17
Pu, J., Kreft, A. F., Aschmies, S., Atchison, K. P., Berkowitz, J. D., Caggiano, T. J., Chlenov, M., Diamantidis, G., Harrison, B. L., Hu, Y., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.052 · Cited by 13
Cited by
Tay, N. E. S., Lehnherr, D., & Rovis, T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00384 · Cited by 518
Ertl, P., Altmann, E., & McKenna, J. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00754 · Cited by 429
Biocatalytic synthesis of oxa(thia)diazole aryl thioethers
Mottaghi Amlashi, D., Mobini, S., Shahedi, M., Habibi, Z., Bavandi, H., & Yousefi, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-70239-3 · Cited by 5
Metadata
- Authors
- Zhao, C., Rakesh, K. P., Ravidar, L., Fang, W.-Y., & Qin, H.-L.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 162
- Pages
- 679-734
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2901960265
- Cited by
- 651
- References
- 133
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.